Insider Transactions in Q1 2017 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q1 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,828
-10.6%
|
$397,260
$45.0 P/Share
|
|
Mar 03
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,828
+9.58%
|
$88,280
$10.57 P/Share
|
|
Mar 01
2017
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
514
+50.0%
|
-
|
|
Mar 01
2017
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
514
+50.0%
|
-
|
|
Feb 08
2017
|
Eric Paques Director |
BUY
Grant, award, or other acquisition
|
Direct |
543
+50.0%
|
-
|
|
Jan 27
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,614
+22.5%
|
-
|
|
Jan 27
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,527
+17.14%
|
-
|
|
Jan 27
2017
|
Michael Gibertini |
BUY
Grant, award, or other acquisition
|
Direct |
10,567
+15.55%
|
-
|
|
Jan 27
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
9,280
+16.11%
|
-
|
|
Jan 20
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,375
-2.54%
|
$68,750
$50.5 P/Share
|
|
Jan 20
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,573
-3.44%
|
$78,650
$50.5 P/Share
|
|
Jan 20
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
1,186
-2.95%
|
$59,300
$50.09 P/Share
|
|
Jan 19
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,334
-2.93%
|
$66,700
$50.65 P/Share
|
|
Jan 19
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,334
+2.85%
|
$56,028
$42.88 P/Share
|
|
Jan 19
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,427
-3.02%
|
$71,350
$50.55 P/Share
|
|
Jan 19
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,077
-2.61%
|
$53,850
$50.55 P/Share
|
|
Jan 19
2017
|
Michael Gibertini |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-1.76%
|
$41,850
$50.55 P/Share
|
|
Jan 05
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,840
-21.49%
|
$771,680
$52.19 P/Share
|
|
Jan 05
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,840
+17.69%
|
$118,720
$8.45 P/Share
|
|
Jan 03
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
41,420
-13.66%
|
$2,153,840
$52.15 P/Share
|
|
Jan 03
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,420
+20.03%
|
$538,460
$13.06 P/Share
|
|
Jan 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
15,383
-8.28%
|
$784,533
$51.99 P/Share
|
|
Jan 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
15,383
+9.93%
|
$184,596
$12.23 P/Share
|